A Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy
Carboplatin is commonly used for the treatment of ovarian cancer in first- and second-line
therapy. The efficacy of gemcitabine in ovarian carcinoma was researched in various Phase 2
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Time to progressive disease
Jacobus Pfisterer, Prof. Dr. med.
AGO Study Group
Germany: Federal Institute for Drugs and Medical Devices